Benchmark Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Benchmark Holdings şirketinin toplam hissedar öz sermayesi £253.4M ve toplam borcu £80.9M olup, bu da borç-öz sermaye oranını 31.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla £407.4M ve £154.0M dir.

Anahtar bilgiler

31.9%

Borç/özkaynak oranı

UK£80.92m

Borç

Faiz karşılama oranı	n/a
Nakit	UK£16.98m
Eşitlik	UK£253.43m
Toplam yükümlülükler	UK£153.96m
Toplam varlıklar	UK£407.39m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 31B 'nin kısa vadeli varlıkları ( £134.2M ) kısa vadeli yükümlülüklerini ( £49.5M ) aşıyor.

Uzun Vadeli Yükümlülükler: 31B şirketinin kısa vadeli varlıkları ( £134.2M ) uzun vadeli yükümlülüklerini ( £104.4M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 31B 'nin net borç/öz sermaye oranı ( 25.2% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 31B şirketinin borç/öz sermaye oranı son 5 yılda 28.3% seviyesinden 31.9% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: Kârsız olan 31B mevcut pozitif serbest nakit akışı seviyesini koruduğu takdirde 3 yıldan fazla yetecek nakit pistine sahip olacaktır.

Tahmini Nakit Akışı: 31B kârlı değildir ancak serbest nakit akışının pozitif olması ve yılda % 46.3 oranında büyümesi nedeniyle 3 yıldan fazla bir süre yetecek nakit akışına sahiptir.

Benchmark Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released: UK£0.013 loss per share (vs UK£0.007 loss in 3Q 2023)

Second quarter 2024 earnings released: UK£0.002 loss per share (vs UK£0.004 loss in 2Q 2023)

First quarter 2024 earnings released: UK£0.01 loss per share (vs UK£0.002 loss in 1Q 2023)

Benchmark Holdings plc to Report Q4, 2024 Results on Nov 27, 2024

Benchmark Holdings plc Announces Directorate Change

Benchmark Holdings plc, Annual General Meeting, Feb 08, 2024

Full year 2023 earnings released: UK£0.024 loss per share (vs UK£0.046 loss in FY 2022)

Benchmark Holdings plc Announces Changes to its Board

Third quarter 2023 earnings released: UK£0.007 loss per share (vs UK£0.019 loss in 3Q 2022)

Benchmark Holdings plc Announces Board Changes

Second quarter 2023 earnings released: UK£0.004 loss per share (vs UK£0.005 loss in 2Q 2022)

Independent Non-Executive Director recently bought €86k worth of stock

First quarter 2023 earnings released: UK£0.002 loss per share (vs UK£0.008 loss in 1Q 2022)

Forecast to breakeven in 2025

Less than half of directors are independent

Benchmark Holdings plc to Report Q3, 2023 Results on Aug 23, 2023

Benchmark Holdings plc has completed a Follow-on Equity Offering in the amount of NOK 158.437575 million.

Benchmark Holdings plc has completed a Follow-on Equity Offering in the amount of NOK 158.437575 million.

Benchmark Holdings plc, Annual General Meeting, Dec 16, 2023

Forecast to breakeven in 2024

Benchmark Holdings plc to Report Q4, 2022 Results on Nov 30, 2022

Less than half of directors are independent

Forecast to breakeven in 2025

Third quarter 2022 earnings released: UK£0.019 loss per share (vs UK£0.004 loss in 3Q 2021)

Benchmark Holdings plc to Report Q3, 2022 Results on Aug 25, 2022

Second quarter 2022 earnings released

Less than half of directors are independent

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Benchmark Holdings plc to Report Q1, 2022 Results on Feb 22, 2022

No longer forecast to breakeven

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Benchmark Holdings plc Announces Environmental Recognition for CleanTreat®

Forecast to breakeven in 2023

Benchmark Holdings plc Provides Revenue Guidance for the Second Half of 2021

Third quarter 2021 earnings released: UK£0.004 loss per share (vs UK£0.008 loss in 3Q 2020)

No longer forecast to breakeven

Second quarter 2021 earnings released: UK£0.005 loss per share (vs UK£0.023 loss in 2Q 2020)

Benchmark Holdings plc Provides Revenue Guidance for the Second Half of 2021

Independent Non-Executive Director recently bought €138k worth of stock

First quarter 2021 earnings released: UK£0.001 loss per share (vs UK£0.01 loss in 1Q 2020)

Revenue beats expectations

Independent Non-Executive Director has left the company

Benchmark Holdings plc to Report Q1, 2021 Results on Feb 22, 2021

New 90-day high: €0.71

Benchmark Holdings plc, Annual General Meeting, Feb 09, 2021

Full year 2020 earnings released: UK£0.038 loss per share

Revenue misses expectations

Hugo Wahnish Intends to Resign as Non-Executive Director of Benchmark Holdings plc, Effective February 9, 2021

New 90-day high: €0.58

Benchmark Holdings plc to Report Fiscal Year 2020 Results on Nov 27, 2020

New 90-day high: €0.53

CEO & Director recently bought €93k worth of stock

Third quarter earnings released

The management team of FAI Farms acquired FAI Farms Ltd from Benchmark Holdings plc (AIM:BMK) in management buyout transaction.

New 90-day high - €0.48

Benchmark Holdings plc to Report Q3, 2020 Results on Aug 28, 2020

Cell And Gene Therapy Catapult completed the acquisition of the vaccine manufacturing facility at Braintree from Benchmark Holdings plc (AIM:BMK).

New 90-day high - €0.45

Cell And Gene Therapy Catapult signed an agreement to acquire vaccine manufacturing facility at Braintree from Benchmark Holdings plc (AIM:BMK) for £12 million.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin